Spruce Biosciences, Inc. (SPRB)
NASDAQ · Manufacturing · Pharmaceutical preparations
SPRB price, last 12 months
Key stats
- Previous close
- $40.84
- Open
- $41.87
- Day range
- $40.03 – $45.42
- 52-week range
- $38.00 – $115.00
- Volume
- 48.1K
- Avg volume (20 days)
- 75.4K
- Market cap
- $124.5M
Performance
Technicals and fundamentals
About Spruce Biosciences, Inc.
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company develops biologics and small-molecule product candidates aimed at addressing diseases with unmet medical needs and limited or no approved therapies. Its product candidate, TA-ERT for the treatment of Mucopolysaccharidosis Type IIIB (MPS IIIB), is a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase (rhNAGLU) intended as an enzyme replacement therapy for patients who lack rhNAGLU enzyme activity. TA-ERT is designed to restore rhNAGLU enzyme activity in the central nervous system following intracerebroventricular injection and promote clearance of heparan sulfate in the brain.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $124.5M